Mon, Jul 14, 2014, 12:02 AM EDT - U.S. Markets open in 9 hrs 28 mins


% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • dare_dog_dare2 dare_dog_dare2 Jan 7, 2008 2:48 PM Flag

    Gooburpeez's relentless pursuit

    Nice to see you posting again ruffy!

    Here's a sampling of chrt13's "expertise:"

    Feb 10, 2006 "Both of their real high-margin drugs (Lipitor and Celebrex) are going to ramp up nicely in '06 "

    More from Feb 10, 2006 "The stock won't even sniff a price as low on the close as the $23.78 seen on Jan. 3. The 30% minimum range theory which almost never fails tells me to expect the stock to get at least to $31 this year. I'm confident enough about that to have made a Loser Leaves Board wager with chartopotamus2003.

    I'm liking that wager better than ever along about now."

    Jan 18, 2006 charty sez: "Don't you know that McKinnell expects to see dramatic improvement out of Celebrex starting this year?"

    Nov 30, 2005 "I definitely DO see double-digit EARNINGS growth - starting in 2007. "

    Jan 21, 2005 he says "The FDA Advisory Committee on Cox-2's convenes three weeks from this coming Wednesday. I expect that their report will do for PFE what the Boies report did for Tyco. It will provide cover for physicians to recommend Celebrex and Bextra again to arthritis patients in normal dosages without having to be worried about malpractice lawsuits... At any rate, the consensus analysts' estimate for '06 is $2.23 per share as compared with a $2.15 estimate for '05. So even in absolutely their worst year, analysts do NOT foresee an earnings decline."

    And on Feb 6, 2005 chartnuts sez: "The Cox-2 nonsense is going to disappear in two weeks when the FDA Advisory Committee convenes. There may be warnings for high-risk heart patients but it's a foregone conclusion that the drugs will remain on the market. And when that is made official, there will be quite a few earnings upgrades. That's because many analysts have completely eliminated Celebrex and Bextra from revenue and earnings consideration "in the interests of conservatism." When absolutely NOTHING is factored in and the drugs remain on the market, what do you suppose will happen with the estimates. PFE should be a low-30's stock by year-end and close to $40 by the end of '06."

    August 24, 2005 the idiot sez: "Bextra was removed from the market. However, a lot of Bextra users will now switch to Celebrex... With the cost-cutting, management now expects double-digit earnings growth to resume next year after only a one-year hiatus. Management now sees PFE as being a double-digit earnings grower for the foreseeable future whereas many investors and analysts viewed this as a 3 or 4% grower."

    Eternally Wrong chartnuts!

    SortNewest  |  Oldest  |  Most Replied Expand all replies
30.07+0.07(+0.23%)Jul 11 4:01 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.